With the acquisition of The New York Stem Cell Foundation (NYSCF), The Jackson Laboratory (JAX) is advancing a bold new model for biomedical research — one that seamlessly connects the power of mouse, cell, and computational systems to accelerate progress from discovery to therapy.
This expanded platform brings together JAX’s global leadership in mouse genetics and preclinical modeling with NYSCF’s world-class expertise in stem cell science, automation, and high-throughput discovery. Combined with AI-powered data analysis, these strengths form an integrated discovery engine that enables scientists to reveal disease mechanisms earlier and test therapies with greater precision.
Together, we are transforming what’s possible for researchers and the patients whose lives depend on discovery — turning possibility into progress.
"The future isn't about choosing one model over another, it's about integrating them. By bringing together mouse, cell and AI models, we will increase success and reduce the costs of life-changing research not only at JAX and NYSCF, but across the scientific community."
- Lon Cardon, JAX president and CEO
The bold new alliance between The Jackson Laboratory (JAX) and The New York Stem Cell Foundation (NYSCF) promises to transform biomedical research and bring life-changing therapies to patients faster than ever before.
View more
In his own words, JAX President and CEO Lon Cardon reflects on his vision for the JAX‑NYSCF Collaborative, and how this powerful partnership brings together people, ideas and innovation to accelerate discoveries and improve human health.
View more
Daniel Paull, who joins JAX from NYSCF as the vice president of discovery and platform development, has spent his career at the intersection of biology and engineering
View moreDeveloped by NYSCF scientists and engineers, the NYSCF Global Stem Cell Array® is a fully robotic platform that brings the power of automation to stem cell research and disease modeling, enabling scientists to study how disease affects patient populations.
The Jackson Laboratory has acquired The New York Stem Cell Foundation to transform biomedical research and accelerate precision therapies for patients.
Behind every new treatment and cure is bold, relentless research. At JAX, we're pushing the boundaries of science to build a healthier future -- but we can't do it alone.